Insider Transactions in Q3 2023 at Acadia Pharmaceuticals Inc (ACAD)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2023
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-15.65%
|
$50,000
$25.88 P/Share
|
|
Aug 21
2023
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-38.94%
|
$290,000
$29.0 P/Share
|
|
Jul 14
2023
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
100,000
-73.16%
|
$3,000,000
$30.04 P/Share
|
|
Jul 14
2023
|
Stephen Davis CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+42.25%
|
$2,000,000
$20.77 P/Share
|
|
Jul 12
2023
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
55,104
-60.03%
|
$1,377,600
$25.05 P/Share
|
|
Jul 11
2023
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
16,498
-15.23%
|
$412,450
$25.0 P/Share
|